Clinical Trials Logo

Clinical Trial Summary

This study is to evaluate the efficacy of urine biomarker in patients with interstitial cystitis/painful bladder syndrome


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT02331472
Study type Observational [Patient Registry]
Source Asan Medical Center
Contact
Status Completed
Phase
Start date February 3, 2015
Completion date January 14, 2016

See also
  Status Clinical Trial Phase
Terminated NCT03143920 - Hyperbaric Oxygen Therapy for Inflammatory Conditions of the Urinary Bladder Early Phase 1
Not yet recruiting NCT04734106 - Safety and Efficacy of Aloe Vera in the Management of the Symptoms of Interstitial Cystitis Early Phase 1
Recruiting NCT06299683 - Pain Type and Interstitial Cystitis/Bladder Pain Syndrome Treatment N/A
Not yet recruiting NCT06013449 - Efficacy of Pulsed Electromagnetic Field and Heparin/Bupivacaine Instillations N/A
Active, not recruiting NCT02858453 - Efficacy and Safety of 2 Doses of AQX-1125 in Subjects With Interstitial Cystitis / Bladder Pain Syndrome Phase 3
Completed NCT01879683 - A Safety, Tolerability and Preliminary Efficacy Study of LiRIS® 400 mg in Women With Interstitial Cystitis (IC) and Hunner's Lesions Phase 1
Completed NCT04275297 - Optimizing Psychosocial Treatment of Interstitial Cystitis/Bladder Pain Syndrome N/A
Completed NCT05744908 - Pentosan Polysulfate Treatment's Effectiveness N/A
Completed NCT04540887 - PEMF Therapy to Treat Interstitial Cystitis/Bladder Pain Syndrome N/A
Recruiting NCT05149573 - Investigation of PEMF Therapy for Female Patients With IC/BPS N/A